Neurocrine Biosciences | NBIX - PE Price to Earnings

Stock Price
140.56
Daily Change
2.70 1.96%
Monthly
2.34%
Yearly
-6.61%
Q1 Forecast
131.87

Neurocrine Biosciences reported $33.27 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
AbbVie USD 24.03 86.23 Dec/2025
Acadia Pharmaceuticals USD 13.7 2.49 Sep/2025
Agios Pharmaceuticals USD 2.88 0.36 Jun/2025
ALKERMES USD 14.9 1.11 Sep/2025
Amgen USD 9.49 3.02 Sep/2025
Biogen USD 9.38 3.02 Sep/2025
BioMarin Pharmaceutical USD 19.45 4.32 Sep/2025
Dynavax Technologies USD 13.52 34.14 Sep/2025
Exelixis USD 16.06 4.35 Sep/2025
Gilead Sciences USD 15.72 0.32 Sep/2025
Halozyme Therapeutics USD 15.46 3.56 Sep/2025
Incyte USD 17.63 2.86 Sep/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
Neurocrine Biosciences USD 33.27 9.34 Sep/2025
Pfizer USD 9.3 1.57 Sep/2025
Prothena USD 22.11 11.37 Mar/2022
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Repligen USD 140.18 14.95 Sep/2025
Sarepta Therapeutics USD 27.27 0 Jun/2025
Teva Pharmaceutical Industries USD 10.11 1.04 Dec/2025
Vertex Pharmaceuticals USD 23.93 3.88 Sep/2025